175 related articles for article (PubMed ID: 34293228)
1. Controlling Coagulation in Blood with Red Light.
Müller P; Sahlbach M; Gasper S; Mayer G; Müller J; Pötzsch B; Heckel A
Angew Chem Int Ed Engl; 2021 Oct; 60(41):22441-22446. PubMed ID: 34293228
[TBL] [Abstract][Full Text] [Related]
2. A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity.
Bompiani KM; Monroe DM; Church FC; Sullenger BA
J Thromb Haemost; 2012 May; 10(5):870-80. PubMed ID: 22385910
[TBL] [Abstract][Full Text] [Related]
3. A simple, general approach of allosteric coagulation enzyme inhibition through monosulfated hydrophobic scaffolds.
Sidhu PS; Zhou Q; Desai UR
Bioorg Med Chem Lett; 2014 Dec; 24(24):5716-5720. PubMed ID: 25453807
[TBL] [Abstract][Full Text] [Related]
4. Increased anticoagulant activity of thrombin-binding DNA aptamers by nanoscale organization on DNA nanostructures.
Rangnekar A; Zhang AM; Li SS; Bompiani KM; Hansen MN; Gothelf KV; Sullenger BA; LaBean TH
Nanomedicine; 2012 Jul; 8(5):673-81. PubMed ID: 21889476
[TBL] [Abstract][Full Text] [Related]
5. PEGylated cyanine dye nanoparticles as photothermal agents for mosquito and cancer cell control.
Xu Q; Shen Y; Zhang Y; Shao X
Bioorg Med Chem Lett; 2019 Aug; 29(16):2398-2404. PubMed ID: 31201064
[TBL] [Abstract][Full Text] [Related]
6. Micellar Thrombin-Binding Aptamers: Reversible Nanoscale Anticoagulants.
Roloff A; Carlini AS; Callmann CE; Gianneschi NC
J Am Chem Soc; 2017 Nov; 139(46):16442-16445. PubMed ID: 29135251
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulant characteristics of HD1-22, a bivalent aptamer that specifically inhibits thrombin and prothrombinase.
Müller J; Freitag D; Mayer G; Pötzsch B
J Thromb Haemost; 2008 Dec; 6(12):2105-12. PubMed ID: 18826387
[TBL] [Abstract][Full Text] [Related]
8. A potent anti-coagulant RNA aptamer inhibits blood coagulation by specifically blocking the extrinsic clotting pathway.
Gopinath SC; Shikamoto Y; Mizuno H; Kumar PK
Thromb Haemost; 2006 May; 95(5):767-71. PubMed ID: 16676065
[TBL] [Abstract][Full Text] [Related]
9. Aptamer RA36 inhibits of human, rabbit, and rat plasma coagulation activated with thrombin or snake venom coagulases.
Savchik EY; Kalinina TB; Drozd NN; Makarov VA; Zav'yalova EG; Lapsheva EN; Mudrik NN; Babij AV; Pavlova GV; Golovin AV; Kopylov AM
Bull Exp Biol Med; 2013 Nov; 156(1):44-8. PubMed ID: 24319726
[TBL] [Abstract][Full Text] [Related]
10. Fine-tuning the properties of the thrombin binding aptamer through cyclization: Effect of the 5'-3' connecting linker on the aptamer stability and anticoagulant activity.
Riccardi C; Meyer A; Vasseur JJ; Russo Krauss I; Paduano L; Morvan F; Montesarchio D
Bioorg Chem; 2020 Jan; 94():103379. PubMed ID: 31699393
[TBL] [Abstract][Full Text] [Related]
11. The Research Progress of Direct Thrombin Inhibitors.
Sun ZG; Yang-Liu ; Zhang JM; Cui SC; Zhang ZG; Zhu HL
Mini Rev Med Chem; 2020; 20(16):1574-1585. PubMed ID: 31644402
[TBL] [Abstract][Full Text] [Related]
12. Effects of extracts and isolated compounds from safflower on some index of promoting blood circulation and regulating menstruation.
Yao D; Wang Z; Miao L; Wang L
J Ethnopharmacol; 2016 Sep; 191():264-272. PubMed ID: 27286914
[TBL] [Abstract][Full Text] [Related]
13. Aptamer Conjugated RNA/DNA Hybrid Nanostructures Designed for Efficient Regulation of Blood Coagulation.
Rolband LA; Ke W; Afonin KA
Methods Mol Biol; 2023; 2709():277-286. PubMed ID: 37572288
[TBL] [Abstract][Full Text] [Related]
14. Chemistry and biology of the peptide anticoagulant D-MePhe-Pro-Arg-H (GYKI-14766).
Bajusz S
Adv Exp Med Biol; 1993; 340():91-108. PubMed ID: 8154347
[No Abstract] [Full Text] [Related]
15. Surfing the Blood Coagulation Cascade: Insight into the Vital Factor Xa.
Núñez-Navarro NE; Santana FM; Parra LP; Zacconi FC
Curr Med Chem; 2019; 26(17):3175-3200. PubMed ID: 29376487
[TBL] [Abstract][Full Text] [Related]
16. Review of the Pharmacology of the Emerging Possibilities of the Direct Oral Anticoagulants' Reversal.
Samos M; Stanciakova L; Skornova I; Bolek T; Kovar F; Stasko J; Galajda P; Mokan M; Kubisz P
Curr Drug Metab; 2017; 18(7):643-650. PubMed ID: 28412907
[TBL] [Abstract][Full Text] [Related]
17. Using photons to manipulate enzyme inhibition by an azobenzene-modified nucleic acid probe.
Kim Y; Phillips JA; Liu H; Kang H; Tan W
Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6489-94. PubMed ID: 19359478
[TBL] [Abstract][Full Text] [Related]
18. Selective light-triggered release of DNA from gold nanorods switches blood clotting on and off.
de Puig H; Cifuentes Rius A; Flemister D; Baxamusa SH; Hamad-Schifferli K
PLoS One; 2013; 8(7):e68511. PubMed ID: 23894311
[TBL] [Abstract][Full Text] [Related]
19. A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release.
Steen Burrell KA; Layzer J; Sullenger BA
J Thromb Haemost; 2017 Sep; 15(9):1807-1817. PubMed ID: 28632925
[TBL] [Abstract][Full Text] [Related]
20. Novel anticoagulants based on direct inhibition of thrombin and factor Xa.
Gardell SJ; Sanderson PE
Coron Artery Dis; 1998; 9(2-3):75-81. PubMed ID: 9647407
[No Abstract] [Full Text] [Related]
[Next] [New Search]
